
Tempus AI valuation is a complex topic, but essentially, it's a measure of the company's worth based on its financial performance and growth potential.
Tempus AI has received significant funding, with a $150 million Series E round in 2020, bringing its total valuation to $3.1 billion.
This valuation is a testament to the company's innovative approach to healthcare technology, which leverages artificial intelligence to analyze medical data and improve patient outcomes.
With a strong financial backing, Tempus AI is well-positioned for future growth and expansion, potentially leading to increased valuation in the years to come.
Financial Statements
Tempus AI's financial statements paint a picture of a company with significant revenue, but also substantial losses. The company had revenue of $693.40 million in the last 12 months.
The income statement reveals a net loss of -$746.33 million, with a loss per share of -$6.23. This suggests that the company is not yet profitable, but it's worth noting that it's still in the early stages of development.
The balance sheet shows that Tempus AI has a total of $679.4 million in current assets, with $466.3 million of that being cash and short-term investments. This is a significant amount of liquidity, but it's also worth noting that the company has a total of $665.4 million in non-current liabilities, including $439 million in long-term debt.
Here's a breakdown of Tempus AI's current and non-current assets and liabilities:
In terms of cash position, the company has $448.26 million in cash, but also has $468.09 million in debt, resulting in a net cash position of -$19.83 million or -$0.13 per share.
Take a look at this: Financial Position of the United States
Balance Sheet
A company's balance sheet is a snapshot of its financial situation at a particular point in time. It's a crucial tool for investors, creditors, and analysts to understand a company's liquidity, solvency, and overall financial health.
The balance sheet typically consists of assets, liabilities, and equity. Assets are resources a company owns or controls, such as cash, inventory, and property. In the case of Tempus AI Inc, its current assets total $679.4 million, with $466.3 million in cash and short-term investments.
Liabilities are amounts a company owes to others, such as accounts payable and debt. Tempus AI Inc has $252.6 million in current liabilities and $665.4 million in non-current liabilities. This includes $439 million in long-term debt.
Equity represents the ownership interest in a company and is typically the difference between assets and liabilities. Tempus AI Inc's equity is not explicitly stated in the provided balance sheet, but we can infer it from the net cash position. The company has a net cash position of -$19.83 million, which is the difference between its cash and total debt.
Here's a breakdown of Tempus AI Inc's net cash position:
This net cash position gives us an idea of the company's liquidity and ability to meet its short-term obligations.
Income Statement
The income statement is a crucial financial statement that provides a snapshot of a company's revenue and expenses over a specific period. It's often referred to as the "bottom line" because it shows the company's net income or loss.
Tempus AI's income statement for the last 12 months reveals a significant loss of $746.33 million. This is a substantial amount of money, and it's essential to understand the underlying factors that contributed to this loss.
The company's revenue was $693.40 million, which is a decent amount, but it wasn't enough to cover its expenses. In fact, Tempus AI reported a gross profit of $381.11 million, but this was still not enough to offset its operating income loss of $691.08 million.
Here's a breakdown of Tempus AI's income statement:
The loss per share of $6.23 indicates that each shareholder suffered a loss of $6.23 per share. This can have a significant impact on investors and may affect the company's stock price.
Taxes
Taxes are an essential part of any business's financial picture. Tempus AI's tax payments over the past year are a notable aspect of their financial statements.
In the past 12 months, Tempus AI has paid a significant amount in taxes, totaling $266,000. This amount is a substantial portion of their overall financial outlays.
Their tax payments are primarily made up of income tax, which accounts for the entire $266,000 paid out.
For another approach, see: Interac E Transfer Maximum Amount
Profitability and Growth
Tempus AI Inc's profitability score is a mere 25/100, indicating that the company is not very profitable. This low score raises concerns about the company's financial health.
The Return on Assets (Normalized) for Tempus AI Inc is a staggering -24.90%, which is significantly lower than its competitors, 603122 and 688468, with return on assets of 2.00% and 6.26% respectively.
A look at the Return on Equity (Normalized) shows that Tempus AI Inc has no available data, whereas its competitors have return on equity of 2.54% and 8.17% respectively.
The Return on Invested Capital (Normalized) is also not available for Tempus AI Inc, but its competitors have return on invested capital of 2.18% and 6.71% respectively.
Here's a comparison of the Return on Assets (Normalized) for the three companies:
Market Analysis
Tempus AI has raised a total of $100 million in funding, with a valuation of $1 billion, making it one of the most valuable AI startups in the market.
The company's valuation is a testament to its innovative approach to healthcare, which has been recognized by investors and industry experts alike.
Comparisons and Ratios
Tempus AI's valuation ratios are worth taking a closer look at. Its Price-to-Sales (PS) Ratio is 12.02, which is significantly higher than the industry average of 3.5x.
The company's PS Ratio is also compared to its peers, with a Forward PS of 15.6x, making it one of the most expensive in the industry. In comparison, the peer average is 4.7x.
Here's a quick glance at the PS Ratios of Tempus AI and its peers:
Ratio vs Peers
Comparing TEM's Price-to-Sales Ratio to its peers reveals a significant difference. TEM's PS Ratio is 15.6x, which is much higher than the peer average of 4.7x. This suggests that TEM is relatively expensive compared to its peers.
Let's take a look at the specific numbers:
As we can see, TEM's PS Ratio is significantly higher than all its peers, with MEDP Medpace Holdings being the closest at 6.9x. This suggests that investors may be paying a premium for TEM's growth prospects, but it also raises concerns about the company's valuation.
Intriguing read: TEM (currency)
Analyst Targets
Analyst Targets are an essential tool for investors to gauge a stock's potential performance. The average price target for Tempus AI is $60.40, which is lower than the current share price.
This lower target price is due to a consensus rating of "Buy" from analysts, indicating a potential increase in the stock's value. Analysts' submissions are updated throughout the day, with 16 analysts covering Tempus AI, including notable firms like BofA Global Research and BTIG.
The price target difference between the current share price and the predicted 1-year target price is -14.33%. This significant difference suggests that investors may be expecting a substantial increase in the stock's value over the next year.
Here's a summary of the average 1-year price targets for Tempus AI:
The average 1-year price target for Tempus AI is $59.77, with a low forecast of $50.5 and a high forecast of $77.7.
Data and Sources
For our Tempus AI valuation analysis, we rely on high-quality data from trusted sources. The data used in our analysis comes from S&P Global Market Intelligence LLC, which provides a comprehensive view of the company's financials.
We use data from various sources, including company financials, analyst consensus estimates, market prices, ownership, management, and key developments. This data is normalized, which may introduce a delay in availability.
The timeframe for our data varies by source, with company financials spanning 10 years, analyst consensus estimates covering +3 years, and market prices extending to 30 years. Ownership, management, and key developments also span 10 years.
Here's a breakdown of the data sources we use:
We also draw from analyst sources, including Tempus AI, Inc., which is covered by 16 analysts. 14 of those analysts submitted estimates used in our report, and their submissions are updated throughout the day.
Here are a few of the analysts who contributed to our analysis:
- Michael Ryskin from BofA Global Research
- Mark Massaro from BTIG
- Kyle Mikson from Canaccord Genuity
Statistics and Shares
Tempus AI has a significant number of shares outstanding, with 157.45 million shares currently in circulation.
The number of shares has increased dramatically over the past year, with a 89.32% increase in shares outstanding. This is a substantial growth, and it's likely that investors are taking notice.
As of now, the company has 152.40 million shares in its current share class. This is a key metric to understand the company's capital structure.
The float, or publicly traded shares, accounts for 80.40 million of the total shares outstanding. This is a significant portion of the company's shares.
Here's a breakdown of the ownership structure:
It's worth noting that the ownership structure is quite diverse, with a significant portion of shares held by institutions and insiders.
Frequently Asked Questions
What is the revenue of Tempus AI?
Tempus AI's revenue is $951.98M in the last 12 months, with a 59.84% year-over-year growth. The company's annual revenue in 2024 was $693.40M, with 30.38% growth.
Featured Images: pexels.com


